Noel Alaka Joins COTA’s Life Science Team to Accelerate Adoption of Oncology Real-World Data

New York, NY / July 7, 2022 COTA, Inc., an oncology real-world data and analytics company, announced today that Noel Alaka will join the company as Vice President of Life Sciences. Noel will be responsible for helping grow and build partnerships with leading life sciences companies that are looking to adopt real-world data and real-world evidence to help accelerate innovation in treatments for patients facing cancer.

A benchtop scientist by training, Noel has worked across many functions within the life sciences industry over the last decade. Most recently, he held a Senior Director of Business Development & Alliance Management role at Parexel — one of the world’s leading global clinical research organizations. At Parexel, he helped to build and expand real-world data and real-world evidence services. Prior to that, Noel worked in clinical development at Sanofi in Cambridge, Massachusetts.

At COTA, Noel will continue his work advocating for patients and helping to advance therapeutic and diagnostic options for those in need. He’ll fulfill this personal mission by helping to expand relationships with life sciences companies that are embracing digital innovation and oncology real-world data as part of their growth strategy.

“Like far too many other people, cancer has hit close to home on more than one occasion. These personal experiences with cancer have helped guide my career. I take great pride in building strategic relationships with life science companies that are looking to adopt the latest tools and technologies aimed at helping to reimagine innovation for the benefit of cancer patients. COTA has proven the utility of its real-world data and advanced analytical services to help life science organizations expedite oncology precision medicine. I’m thrilled to join the COTA team and join their mission of bringing clarity to cancer.”

Based in California, Noel is a motivated triathlete, loving husband, and lifelong learner. He also recently earned a specialized MBA in digital transformation, strategy and technology innovation, and entrepreneurship from the University of California, Irvine’s Paul Merage School of Business. He was awarded with the Dean’s Scholar Award for his overall outstanding academic performance and for graduating top of his class.

“Noel is a seasoned business development professional who understands the intricacies of the drug development process from the inside out. As we continue our efforts to bring clarity to cancer care here at COTA, we are swiftly expanding our life science team. Noel’s experience will help fuel our growth while driving much-needed broader adoption of oncology real-world data in the push toward precision medicine.”